Learn why longitudinal imaging workflows in neuro-oncology clinical trials need a subject-centric approach to improve consistency, traceability, and...
Explore how RANO 2.0, AI-assisted imaging, and evolving regulatory expectations are changing neuro-oncology clinical trials and imaging workflows.
Learn the key challenges of medical AI validation and how cloud-based platforms streamline AI validation medical imaging workflows for clinical...
Discover how the new McDonald criteria use imaging biomarkers such as the Central Vein Sign (CVS) to make earlier, more accurate MS diagnosis
Parkinson’s Disease (PD) is the second most prevalent neurodegenerative disorder worldwide. Over 750 industry clinical trials have been initiated for...
Learn how QMENTA simplifies central vein detection in Multiple Sclerosis. Our solution automates protocol adherence, sequence recognition, and white...
QMENTA's neuroimaging platform enables Parkinson's disease research through AI-powered MRI and PET biomarker analysis — including iron accumulation,...
Discover how the Central Vein Sign (CVS) — with 95% sensitivity and 92% specificity — is transforming MS diagnosis and how QMENTA powered the CAVS-MS...
Compare the top 4 open-source brain morphometry tools — FreeSurfer, FastSurfer, ANTs, and SIENA (FSL) — for cortical thickness, volumetry, and brain...